INTRODUCTION (18)F-FDG-PET-CT plays an important role in the management of lymphoma postchemotherapy followup. Some centres perform prechemotherapy baseline CT and postchemotherapy PETCT. With a concern of radiation burden, especially in young patients, this study aimed to assess if PETCT radiation dose could be reduced. METHODS Retrospective analysis of 100 lymphoma patients was performed to...

temporal bone chondroblastoma is an extremely rare benign bone tumor. we encountered two cases showing similar imaging findings on computed tomography (ct), magnetic resonance imaging (mri), and dual-time-point 18f-fluorodeoxyglucose (18f-fdg) positron emission tomography (pet)/ct. in both cases, ct images revealed temporal bone defects and sclerotic changes around the tumor. most parts of the ...

Abstract Background Pancreatic neuroendocrine tumor (PNET) is a subgroup of (NET) that has unique biology and natural history. The histological classification major role in the management this pathology, but recent years Gallium 68 dotatate (68Ga-DOTA) scanning at center discussion about how these imaging technologies can modify clinical tumors their results are correlated to Ki67 index. Method...

Temporal bone chondroblastoma is an extremely rare benign bone tumor. We encountered two cases showing similar imaging findings on computed tomography (CT), magnetic resonance imaging (MRI), and dual-time-point 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT. In both cases, CT images revealed temporal bone defects and sclerotic changes around the tumor. Most parts of the ...

Brain positron emission tomography (PET) has also been used over many years to diagnose neurodegenerative diseases, and has advantages over MRI due to its higher sensitivity to detect pathologies at a molecular level. While 18F-fluorodeoxyglucose (FDG) PETCT is an established imaging technique for assisting in the differential diagnosis of Alzheimer’s disease (AD) and other forms of dementia, P...

Colorectal cancer represents the second most common malignancy worldwide, with approximately one million newly diagnosed cases each year, and is the fourth leading cause of cancer mortality. This article provides an overview of the role of FDG (fluorodeoxyglucose) PET (positron emission tomography) CT (computed tomography) for assessment in patients with colorectal cancer. A summary of key lear...

RATIONALE AND OBJECTIVE Perform a comprehensive meta-analysis evaluating the diagnostic performance of dual time point deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography (FDG-PET) in the diagnosis of pulmonary nodules. MATERIALS AND METHODS MEDLINE, EMBASE, and PUBMED were queried between January 2000 and January 2011. Studies were included if they: 1) used dual time point FDG-PET a...

AIM To study the influence of dual time point 18F-FDG PET/CT in textural features and SUV-based variables and their relation among them. METHODS Fifty-six patients with locally advanced breast cancer (LABC) were prospectively included. All of them underwent a standard 18F-FDG PET/CT (PET-1) and a delayed acquisition (PET-2). After segmentation, SUV variables (SUVmax, SUVmean, and SUVpeak), me...

The utility of 18F-fl uorodeoxyglucose (FDG)-positron emission tomography (PET) is widely recognized for the management of patients with cancer encompassing several aspects including diagnosis, staging, and monitoring therapeutic intervention1. However, FDG not only accumulates within malignant tumor sites but also in the infl ammatory lesions. As a result, the clinical utility of FDG-PET is al...